DUBLIN, May 1, 2017 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that Paul Campanelli, President and CEO, is scheduled to present at the UBS Global Healthcare Conference in New York on Tuesday, May 23, 2017 at 8 a.m. EDT.  

A live webcast and audio archive for the event will be available on the Company's website at http://www.endo.com/investors/overview. Participants should allow approximately 10 minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.  

About Endo International plc
Endo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endo-to-present-at-ubs-global-healthcare-conference-300448298.html

SOURCE Endo International plc

Endo International plc: Investors/Media: Stephen Mock, (845) 364-4833, Media: Heather Zoumas-Lubeski, (484) 216-6829, Investors: Nina Goworek, (484) 216-6657